APA (7th ed.) Citation

Ellis, R. J., Kaminsky, D. A., Zhou, E. H., Fu, P., Chen, W., Brelin, A., . . . Bodner, D. (2011). Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 81(1), 29. https://doi.org/10.1016/j.ijrobp.2010.05.053

Chicago Style (17th ed.) Citation

Ellis, Rodney J., Deborah A. Kaminsky, Esther H. Zhou, Pingfu Fu, Wei-Dong Chen, Alaina Brelin, Peter F. Faulhaber, and Donald Bodner. "Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer." International Journal of Radiation Oncology, Biology, Physics 81, no. 1 (2011): 29. https://doi.org/10.1016/j.ijrobp.2010.05.053.

MLA (9th ed.) Citation

Ellis, Rodney J., et al. "Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer." International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 1, 2011, p. 29, https://doi.org/10.1016/j.ijrobp.2010.05.053.